Economic Modeling for HIV, Viral Hepatitis, Sexually Transmitted Diseases, Tuberculosis and School Health

The summary for the Economic Modeling for HIV, Viral Hepatitis, Sexually Transmitted Diseases, Tuberculosis and School Health grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Centers for Disease Control and Prevention, which is the U.S. government agency offering this grant.
Economic Modeling for HIV, Viral Hepatitis, Sexually Transmitted Diseases, Tuberculosis and School Health: CDC seeks to support state and local public health efforts to increase the prevention effectiveness of public health interventions. Timely models and economic analyses support both of these goals. The activities described in this FOA will provide models and analytic results that will enable NCHHSTP to better assess policy options, address questions of resource allocation, estimate impact, and characterize the cost-effectiveness of interventions used or potentially used in public health. It is anticipated that these activities will at times require analyses of the types described in Table 1, on the following page. At times CDC is called upon to assess any of the following types of economic issues: • The change in disease incidence or prevalence as a result of changes in factors such as (1) sexual behaviors (e.g., condom use, pre-exposure prophylaxis, anti-retroviral therapy), (2) health-seeking behaviors (e.g., increased HIV and HCV testing), (3) provision or cessation of specific interventions, and (4) changes in prevention resources • The cost of illness of HIV, STDs, viral hepatitis, tuberculosis, and school health issues • The cost of various intervention strategies or health programs • The cost-effectiveness of interventions addressing different public health problems using health outcome measures such as quality-adjusted life years (QALYs): these may include analyses of single interventions or multiple interventions • The cost-effectiveness of alternative interventions addressing the same public health problem using either QALYs or natural health units, such as cases of disease detected or treated • Optimal allocation of resources across diseases, intervention strategies, risk and population groups, etc. • Estimating the overall population-level impact and cost-effectiveness of prevention activities supported by NCHHSTP • The net benefit or return on investment of interventions, clinical practice, recommendations, programs, and policies to reduce HIV, sexually transmitted diseases, viral hepatitis, and tuberculosis, or to improve school health. It is expected that to be able to perform these types of analyses, applicants will have demonstrated capability in at least two of the five areas (HIV, viral hepatitis, tuberculosis, sexually transmitted diseases, and school health), as demonstrated by reports of previous economic analyses or modeling studies that have been published following peer review in journals indexed in PubMed or EconLit. Applicants should have epidemiologic, clinical, modeling, and economic expertise sufficient to define modeling questions, generate hypotheses, conduct literature searches, determine needed data inputs, and construct models to address at least four of the five areas.
Federal Grant Title: Economic Modeling for HIV, Viral Hepatitis, Sexually Transmitted Diseases, Tuberculosis and School Health
Federal Agency Name: Centers for Disease Control and Prevention
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: CDC-RFA-PS14-1415
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.084
CFDA Descriptions: Prevention of Disease, Disability, and Death by Infectious Diseases
Current Application Deadline: Jul 17, 2014 1.Letter of Intent (LOI) Deadline: J
Original Application Deadline: Jul 17, 2014 1.Letter of Intent (LOI) Deadline: J
Posted Date: May 21, 2014
Creation Date: May 21, 2014
Archive Date: Aug 16, 2014
Total Program Funding: $15,000,000
Maximum Federal Grant Award: $0
Minimum Federal Grant Award: $0
Expected Number of Awards: 3
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Private and public colleges and universities;
Government Organizations:
•State or their bona fide agents (includes the District of Columbia)
•Local governments or their bona fide agents
•Territorial governments or their bona fide agents in the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau)
•State controlled institutions of higher education
•American Indian or Alaska Native tribal governments (federally recognized or state-recognized)
•Public Housing Authorities/Indian Housing Authorities;
Non-government Organizations:
•American Indian or Alaska native tribally designated organizations
•Nonprofit with 501C3 IRS status (other than institution of higher education)
•Nonprofit without 501C3 IRS status (other than institution of higher education);
Community-based organizations;
Faith-based organizations;
For-profit organizations (other than small business);
Small businesses.

Grant Announcement Contact
CDC Procurement and Grants Office (PGO) Technical Information Management Section (TIMS) Phone: 770-488-2700

Centers for Disease Control and Prevention 770-488-2756
Similar Government Grants
Modeling Infectious Diseases in Healthcare Research Projects to Improve Prevention Researc...
Detection and Characterization of Emerging Vector-Borne and Zoonotic Pathogens in Indonesi...
Enhanced Surveillance and Control of Arboviruses in Puerto Rico
Economic Modeling for HIV/AIDS, Viral Hepatitis, STD, and TB
Study to Assess the Risk of Blood Borne Transmission of Classic Forms of Creutzfeldt-Jakob...
Impact of Japanese Encephalitis Vaccination in Cambodia
Clinical, Epidemiologic and Ecologic Factors Impacting the Burden and Distribution of Monk...
Reduction of Malaria in U.S. Residents Returning from Overseas Travel to Malaria-Endemic C...
More Grants from the Centers for Disease Control and Prevention
Surveillance and Response to Avian and Pandemic Influenza by National Health Authorities o...
Technical Assistance to Support Comprehensive Combination HIV Prevention, Care and Treatme...
Strengthening Ebola rapid detection and response capacity through community based surveill...
test2 is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2020